Jonathan Mark Hopper - 02 Jun 2026 Form 4 Insider Report for Vericel Corp (VCEL)

Reporting relationship: Chief Medical Officer
Issuer ticker: VCEL
Reported as of: 02 Jun 2026
Net transaction value: -$153,125
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:05:24 UTC
Prior SEC filing: 06 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper

Key filing fact

Jonathan Mark Hopper filed Form 4 for Vericel Corp (VCEL) on 04 Jun 2026.

Key facts

This page summarizes Jonathan Mark Hopper's Form 4 filing for Vericel Corp (VCEL).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 16:05.

Change

Previous filing in this sequence was filed on 06 Apr 2026.
Current net transaction value: -$153,125.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001626325 Primary reporting owner

Hopper Jonathan Mark

Relationship: Chief Medical Officer
Address: 25 BLUE SKY DRIVE, BURLINGTON
Signature: /s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VCEL transaction

Common Stock

Options Exercise

Transaction value
Shares: +4,375
Change %: +5.8%
Price: $16.66^*
Shares after: 80,128
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1

VCEL transaction

Common Stock

Sale

Transaction value: $153,125
Shares: -4,375
Change %: -5.5%
Price: $35.00
Shares after: 75,753
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VCEL transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: +4,375
Change %
Price: $0.000000^*
Shares after: 1,625
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,375
Exercise price: $16.66
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Footnote F2

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2025.

Footnote F3

These options, representing the right to purchase 26,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 6, 2019, which was one quarter after the date on which the option was granted.